Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
07/15/2004 | WO2004058959A1 PROCESS FOR PRODUCING PNPase |
07/15/2004 | WO2004058940A2 Sirna-mediated gene silencing |
07/15/2004 | WO2004058814A1 Enzymes and polynucleotides encoding the same |
07/15/2004 | WO2004058794A1 Methods and compositions for the tandem synthesis of two or more oligonuleotides on the same solid support |
07/15/2004 | WO2004058793A1 Nucleotide derivatives and dna microarray |
07/15/2004 | WO2004058779A1 Process for preparing phosphorodiamidites |
07/15/2004 | WO2004058392A2 Intramolecular triplet-sensitized o-nitrophenylethyl photoprotective groups |
07/15/2004 | WO2004058391A2 Photoactivatable two-stage protective groups for the synthesis of biopolymers |
07/15/2004 | WO2004058300A1 Sequences diagnostic for foot and mouth disease |
07/15/2004 | WO2004058179A2 Immunostimulatory sequence oligonucleotides and methods of using the same |
07/15/2004 | WO2004058166A2 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
07/15/2004 | WO2004058159A2 Branched immunomodulatory compounds and methods of using the same |
07/15/2004 | WO2004058147A2 Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof |
07/15/2004 | WO2004058052A2 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
07/15/2004 | WO2004058042A2 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases |
07/15/2004 | WO2004057940A2 Canine dioxin/aryl hydrocarbon receptor sequences |
07/15/2004 | WO2004049274A3 2’-0-trisubstituted silyloxymethyl-ribonucleoside-derivative and method for preparing the same |
07/15/2004 | WO2004043227A3 Polynucleotides for the amplification and detection of chlamydia trachomatis and neisseria gonorrhoeae |
07/15/2004 | WO2004042363A3 In vivo imaging of e2f-regulated bioluminescent proteins |
07/15/2004 | WO2004041076A3 Methods of detecting colorectal cancer |
07/15/2004 | WO2004032599A3 Novel immunogenic proteins of leptospira |
07/15/2004 | WO2004027081A3 Methods and composition for detecting targets |
07/15/2004 | WO2004026260A3 Prophylactic and therapeutic hiv aptamers |
07/15/2004 | WO2004024744A3 Production of glycosylated macrolides in e. coli |
07/15/2004 | WO2004022713A3 Method for distinguishing ulcerative colitis from crohn's disease by detecting the presence of fecal anti-neutrophil cytoplasmic antibodies (anca) |
07/15/2004 | WO2004007664A3 Nucleic acid vectors |
07/15/2004 | WO2004005322A3 Humanized renilla reniformis green fluorescent protein as a scaffold |
07/15/2004 | WO2003100022A3 Methods and dna constructs for high yield production of polypeptides |
07/15/2004 | WO2003099209A3 Compositions and methods for screening and identifying anti-hcv agents |
07/15/2004 | WO2003070965A9 The eaat2 promoter and uses thereof |
07/15/2004 | US20040139500 Plastid division and related genes and proteins, and methods of use |
07/15/2004 | US20040139497 Comprises expression vector coding insecticidal polypeptide for use in generation and propagation of insect resistant plants; boiological pest control |
07/15/2004 | US20040139487 Transgenic animal and uses thereof |
07/15/2004 | US20040138440 Aspergillus fumigatus cofilin |
07/15/2004 | US20040138166 Viricides; prevent reproduction, infections |
07/15/2004 | US20040138163 Anticancer agents; antiproliferative agents |
07/15/2004 | US20040138117 administering proteins or polypeptides for prophylaxis or diagnosis of nervous system and gastrointerstinal disorders ; genetic engineering; drug screening |
07/15/2004 | US20040137626 AAV ITR-mediated modulation |
07/15/2004 | US20040137579 Protein complexes having factor VIII:C activity and production thereof |
07/15/2004 | US20040137566 Identification of novel ms4a gene family members expressed by hematopoietic cells |
07/15/2004 | US20040137561 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
07/15/2004 | US20040137522 Genes and proteins altering Tau-related neurodegeneration |
07/15/2004 | US20040137502 for diagnosis, drug screening, clinical trial monitoring, the treatment of physiological disorders or infectious disease |
07/15/2004 | US20040137486 correlates known sensory, physical, ingredient, or processing properties (color, taste, texture, pH, moisture content) with a spectrum of target species of microorganisms that are present |
07/15/2004 | US20040137479 Compositions and methods for visual ribonuclease detection assays |
07/15/2004 | US20040137474 by comparing gene patterns for breast cancer; for early diagnosis; kits |
07/15/2004 | US20040137470 determining the sequence of alleles of a locus of interest, and quantitating a ratio for the alleles at said locus which indicates the presence or absence of a chromosomal abnormality; non-invasive method for fetal DNA testing |
07/15/2004 | US20040137469 Peptide Nucleic Acids (PNA); an acid forming cleavable linker and a PNA dimer comprising an N-terminal base labile protecting group, cleavably linked to the solid support through the cleavable linker |
07/15/2004 | US20040137468 Solid phase based nucleic acid assays combining high affinity and high specificity |
07/15/2004 | US20040137453 Process for producing vinylated nucleic acid |
07/15/2004 | US20040137449 Magnetic isolation and purification of nucleic acids |
07/15/2004 | US20040137448 Isolated polypeptide of given sequence; expression vectors, host cells, antibodies, agonists, and antagonists; use in diagnosis and treatment of cell proliferative, neurological, developmental, and autoimmune/inflammatory disorders |
07/15/2004 | US20040137441 Modulation of thyroid hormone receptor interactor 3 expression |
07/15/2004 | US20040137011 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance |
07/15/2004 | US20040137010 gp120 and a nucleic acid aptamer that binds to gp120 and induces gp120 to undergo a conformational shift whereby an epitope to a membrane bound receptor is exposed that is capable of eliciting a humoral immune response |
07/15/2004 | US20040136999 Melanoma antigens and methods of use |
07/15/2004 | US20040136995 antibody, or fragment thereof, that specifically binds an ACT-4-h-1 receptor; has different binding specificity than a monoclonal antibody generated by hybridoma HBL106 |
07/15/2004 | US20040136948 Branched immunomodulatory compounds and methods of using the same |
07/15/2004 | CA2756797A1 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
07/15/2004 | CA2511652A1 Enzymes and polynucleotides encoding the same |
07/15/2004 | CA2511620A1 Nucleotide derivatives and dna microarray |
07/15/2004 | CA2511503A1 Method and device for optimizing a nucleotide sequence for the purpose of expression of a protein |
07/15/2004 | CA2511475A1 Immunostimulatory sequence oligonucleotides and methods of using the same |
07/15/2004 | CA2511012A1 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
07/15/2004 | CA2510895A1 Genetic polymorphisms associated with stenosis, methods of detection and uses thereof |
07/15/2004 | CA2510891A1 Rapid direct sequence analysis of multi-exon genes |
07/15/2004 | CA2510645A1 Releasable polymer arrays |
07/15/2004 | CA2510587A1 Nucleic acid amplification |
07/15/2004 | CA2510362A1 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases |
07/15/2004 | CA2509999A1 Btl-ii nucleic acids, proteins, and antibodies |
07/15/2004 | CA2508985A1 Branched immunomodulatory compounds and methods of using the same |
07/15/2004 | CA2508948A1 Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof |
07/15/2004 | CA2508610A1 Assay for rnase h activity |
07/15/2004 | CA2508228A1 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection |
07/14/2004 | EP1437408A1 Novel antisense oligonucleotide derivatives against hepatitis c virus |
07/14/2004 | EP1437368A1 Composition for polymerising immobilisation of biological molecules and method for producing said composition |
07/14/2004 | EP1436614A1 Methods of detection of conformational change in a nucleic acid duplex by treatment with oxidising or reactive agent as a result of exposure to environmental or chemical conditions |
07/14/2004 | EP1436418A2 Transductin-1 and transductin-2 and applications to hereditary deafness |
07/14/2004 | EP1436404A2 Engineered templates and their use in single primer amplification |
07/14/2004 | EP1436384A2 Mutated abl kinase domains |
07/14/2004 | EP1436328A2 G-protein coupled receptor |
07/14/2004 | EP1436308A2 Antisense modulation of il-1 receptor-associated kinase-4 expression |
07/14/2004 | EP1436014A1 Cationic lipids suitable for gene transfer |
07/14/2004 | EP1436002A1 Use of peptide vectors to improve the immune response to antigens |
07/14/2004 | EP1363935A4 Ter sites and ter binding proteins |
07/14/2004 | EP1337541A4 Massive parallel method for decoding dna and rna |
07/14/2004 | EP0986571B1 Novel sulfur transfer reagents for oligonucleotide synthesis |
07/14/2004 | EP0754227B1 Chimeric complement inhibitor proteins |
07/14/2004 | EP0749442B1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES |
07/14/2004 | EP0604409B1 Oligonucleotide analogs for detecting and modulating rna activity and gene expression |
07/14/2004 | CN1512998A Proteins producing altered immunogenic response and methods of making and using the same |
07/14/2004 | CN1511847A Ubiquitin-like molecule coming from human dendritic cell and its codnig sequence and use |
07/14/2004 | CN1511842A Rockfish insulin-like growth factor I gene and carrier containing said gene and recombined strain and its use |
07/14/2004 | CN1511841A Homoeotic box gene 9Brn-1 from quail and its use |
07/14/2004 | CN1157406C Novel, ATP-sensitive potassium-channel proteins and genes for the same |
07/13/2004 | US6762298 Thermolabile phosphorus protecting groups, associated intermediates and methods of use |
07/13/2004 | US6762290 Includes rna ligands that inhibit the interaction of a vegf receptor with vegf |
07/13/2004 | US6762169 Improved transmembrane delivery of nucleosides conjugated to an arylpropionic acid ligand (ibuprofen) which has affinity for plasma protein albumin; antisense therapy |
07/13/2004 | US6762052 The enzymes are useful in metabolism studies, in screening of compounds for biological or pharmacological activity, as well as serving as a bio-indicator of disease states or susceptibility to disease states |
07/13/2004 | US6762048 System and apparatus for nucleic acid sequencing of single molecules by polymerase synthesis |